TreVia Digital Health builds a device-agnostic platform that aggregates diabetes diagnostic device results and integrates them with EHRs and the cloud. The company has a strong foundation in diabetic retinopathy and expanded into neuropathy, partnering with Prosenex on an FDA-cleared peripheral neuropathy screening device and establishing baselines for pre-diabetes patients. It is developing AI-driven patient engagement (including a collaboration with Thrive) to deliver health-coach–style reminders and lifestyle support. TreVia plans to add population health and predictive analytics capabilities and to target patients vulnerable to complications as well as those with pre-diabetes or recent diagnoses. The company positions itself as complementary to EHR vendors and lists partnerships with Allscripts and athenahealth to integrate diagnostics into clinical workflows. Leadership includes Cerner veteran Jim Higgins (co-founder and VP of engineering), co-founder and CMO Dr. David Dyer, and President/COO Maureen Peszko.

Total raised

$10M

Funding rounds

1

Latest round

Series B

Latest activity

Jan 2016